Eversept Partners, LP Immutep LTD Transaction History

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$3.02 - $5.21 $754,682 - $1.3 Million
-249,895 Closed
0 $0
Q1 2021

Nov 08, 2023
BUY
$2.37 - $3.68 $592,251 - $919,613
249,895 New
249,895 $767,000
Q1 2021

May 13, 2021
BUY
$2.37 - $3.68 $592,251 - $919,613
249,895 New
249,895 $767,000

Others Institutions Holding IMMP

# of Institutions
31
Shares Held
1.86M
Call Options Held
264K
Put Options Held
90.5K
View Full List

About IMMUTEP Ltd

IMMP Quotes by TradingView
  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $176M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email